Share-based Payment Arrangement, Expense of GYRE THERAPEUTICS, INC. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
GYRE THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • GYRE THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,147,000, a 384% increase year-over-year.
  • GYRE THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $3,127,000, a 56% decline year-over-year.
  • GYRE THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $831,000, a 89% decline from 2023.
  • GYRE THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $7,281,000, a 46% decline from 2022.
  • GYRE THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $13,366,000, a 293% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

GYRE THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,127,000 $1,147,000 +$910,000 +384% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $2,217,000 $906,000 +$890,000 +5562% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,327,000 $507,000 +$496,000 +4509% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $831,000 $567,000 -$6,317,000 -92% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 $7,148,000 $237,000 +$139,000 +142% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $7,009,000 $16,000 -$73,000 -82% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $7,082,000 $11,000 -$199,000 -95% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $7,281,000 $6,884,000 -$5,397,000 -44% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $12,678,000 $98,000 -$126,000 -56% 01 Jul 2023 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 $12,804,000 $89,000 -$257,000 -74% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $13,061,000 $210,000 -$305,000 -59% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $13,366,000 $12,281,000 +$11,598,000 +1698% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $1,768,000 $224,000 -$489,000 -69% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 $2,257,000 $346,000 -$637,000 -65% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $2,894,000 $515,000 -$511,000 -50% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $3,405,000 $683,000 -$237,000 -26% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $3,642,000 $713,000 -$355,000 -33% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $3,997,000 $983,000 +$149,000 +18% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $3,848,000 $1,026,000 +$221,000 +27% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $3,627,000 $920,000 +$249,000 +37% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $3,378,000 $1,068,000 +$267,000 +33% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $3,111,000 $834,000 -$69,000 -7.6% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $3,180,000 $805,000 -$24,000 -2.9% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $3,204,000 $671,000 -$76,000 -10% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $3,280,000 $801,000 +$99,000 +14% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $3,181,000 $903,000 +$352,000 +64% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $2,829,000 $829,000 +$223,000 +37% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $2,606,000 $747,000 +$440,000 +143% 01 Oct 2018 31 Dec 2018 10-K 20 Feb 2020 2019 FY
Q3 2018 $2,166,000 $702,000 +$377,000 +116% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $1,789,000 $551,000 +$440,000 +396% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $1,349,000 $606,000 +$486,000 +405% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $863,000 $307,000 +$178,000 +138% 01 Oct 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
Q3 2017 $685,000 $325,000 +$137,000 +73% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $548,000 $111,000 -$54,000 -33% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $602,000 $120,000 -$33,000 -22% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q4 2016 $635,000 $129,000 -$60,000 -32% 01 Oct 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q3 2016 $695,000 $188,000 +$136,000 +262% 01 Jul 2016 30 Sep 2016 10-Q 02 Nov 2017 2017 Q3
Q2 2016 $559,000 $165,000 +$124,000 +302% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $435,000 $153,000 +$109,000 +248% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $326,000 $189,000 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 $52,000 -$4,000 -7.1% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016 2016 Q3
Q2 2015 $41,000 -$20,000 -33% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $44,000 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q3 2014 $56,000 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $61,000 10 Apr 2014 30 Jun 2014 8-K/A 23 Oct 2015

GYRE THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $831,000 -$6,450,000 -89% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $7,281,000 -$6,085,000 -46% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $13,366,000 +$9,961,000 +293% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $3,405,000 -$222,000 -6.1% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $3,627,000 +$423,000 +13% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $3,204,000 +$598,000 +23% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
2018 $2,606,000 +$1,743,000 +202% 01 Jan 2018 31 Dec 2018 10-K 20 Feb 2020 2019 FY
2017 $863,000 +$228,000 +36% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $635,000 +$309,000 +95% 01 Jan 2016 31 Dec 2016 10-K 19 Mar 2018 2017 FY
2015 $326,000 +$82,000 +34% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
2014 $244,000 -$54,000 -18% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2016 2015 FY
2013 $298,000 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.